Literature DB >> 11963457

Cluster-randomized trials.

P M Fayers1, M S Jordhøy, S Kaasa.   

Abstract

Cluster-randomized trials represent an important experimental design, supplementing ordinary randomized clinical trials. They are particularly relevant when evaluating interventions at the level of clinic, hospital, district or region. They are necessary when it is not feasible to randomize individual patients, and desirable when there may be contamination between clusters. But they also carry serious design and analysis implications, and the use of clusters as the unit of randomization must be justified. Sample sizes will usually need to be greatly increased, an adequate number of clusters is essential, and the statistical analysis must allow for the cluster design. And one should rigorously guard against selection bias.

Entities:  

Mesh:

Year:  2002        PMID: 11963457     DOI: 10.1191/0269216302pm503xx

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  11 in total

1.  Adjusted chi-square statistics: application to clustered binary data in primary care.

Authors:  James F Reed
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

2.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

3.  Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Authors:  Amy H Warriner; Ryan C Outman; Adrianne C Feldstein; Douglas W Roblin; Jeroan J Allison; Jeffrey R Curtis; David T Redden; Mary M Rix; Brandi E Robinson; Ana G Rosales; Monika M Safford; Kenneth G Saag
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

4.  Process Evaluation of an Implementation Trial: Design, Rationale, and Early Lessons Learnt From an International Cluster Clinical Trial in Intracerebral Hemorrhage.

Authors:  Menglu Ouyang; Craig S Anderson; Lili Song; Alejandra Malavera; Stephen Jan; Guojuan Cheng; Honglin Chu; Xin Hu; Lu Ma; Xiaoying Chen; Chao You; Hueiming Liu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

5.  A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care.

Authors:  Clare White; Kristen Gilshenan; Janet Hardy
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

Review 6.  Effect of telemedicine follow-up care of leg and foot ulcers: a systematic review.

Authors:  Lena Victoria Nordheim; Marianne Tveit Haavind; Marjolein M Iversen
Journal:  BMC Health Serv Res       Date:  2014-11-06       Impact factor: 2.655

7.  The implementation and sustainability of a combined lifestyle intervention in primary care: mixed method process evaluation.

Authors:  Brenda A J Berendsen; Stef P J Kremers; Hans H C M Savelberg; Nicolaas C Schaper; Marike R C Hendriks
Journal:  BMC Fam Pract       Date:  2015-03-17       Impact factor: 2.497

8.  Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial.

Authors:  Thomas Karagiannis; Aris Liakos; Megan E Branda; Eleni Athanasiadou; Maria Mainou; Panagiota Boura; Dimitrios G Goulis; Annie LeBlanc; Victor M Montori; Apostolos Tsapas
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

9.  Managing uncertain recovery for patients nearing the end of life in hospital: a mixed-methods feasibility cluster randomised controlled trial of the AMBER care bundle.

Authors:  J Koffman; E Yorganci; D Yi; W Gao; F Murtagh; A Pickles; S Barclay; H Johnson; R Wilson; L Sampson; J Droney; M Farquhar; T Prevost; C J Evans
Journal:  Trials       Date:  2019-08-16       Impact factor: 2.279

10.  The effectiveness of multi-component interventions targeting physical activity or sedentary behaviour amongst office workers: a three-arm cluster randomised controlled trial.

Authors:  Carla F J Nooijen; Victoria Blom; Örjan Ekblom; Emerald G Heiland; Lisa-Marie Larisch; Emil Bojsen-Møller; Maria M Ekblom; Lena V Kallings
Journal:  BMC Public Health       Date:  2020-09-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.